Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| UNITED THERAPEUTICS CorpUTHR · Entity 664 | Director | July 22, 2026 | July 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
UNITED THERAPEUTICS Corp
Report date July 22, 2026 · Filed July 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $527.07 · Expires 2033-07-22 | Direct | 2,380 |
Reported balance
After 2026-07-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-22 · Grant · Acquired 2,380 · Balance 2,380 F1: Annual non-employee director award. F2: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders. |
| Common StockSEC Table I · non-derivative | Direct | 4,190 |
Reported balance
Holding disclosure · report date 2026-07-22 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 4,190 |
Filing footnotes · ownership attribution and instrument terms
F1: Annual non-employee director award.
F2: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 22, 2026 Filed Jul 23, 2026 20:38 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Option · Derivative | 2,380 | $0.00 Strike: $527.07 | $0.00 |
DisclosureSEC source: 0001237334-26-000006 · primarydocument.xml · derivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,380 Underlying: Common Stock · 2,380 shares Expires 2033-07-22 F1 · shares: Annual non-employee director award. F2 · derivative.exercise_date: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders. Read SEC document |
| March 30, 2026 Filed Mar 31, 2026 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Option · Derivative | 1,300 | $0.00 Strike: $119.76 | $0.00 |
DisclosureSEC source: 0001237334-26-000005 · primarydocument.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 1,300 shares Expires 2030-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025. Read SEC document |
| March 30, 2026 Filed Mar 31, 2026 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,300 | $604.64 | $786,032.00 |
DisclosureSEC source: 0001237334-26-000005 · primarydocument.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,190 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025. Read SEC document |
| March 30, 2026 Filed Mar 31, 2026 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,300 | $119.76 | $155,688.00 |
DisclosureSEC source: 0001237334-26-000005 · primarydocument.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 21:34 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Option · Derivative | 20 | $0.00 Strike: $119.76 | $0.00 |
DisclosureSEC source: 0001237334-26-000004 · primarydocument.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,300 Underlying: Common Stock · 20 shares Expires 2030-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 21:34 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 20 | $490.17 | $9,803.37 |
DisclosureSEC source: 0001237334-26-000004 · primarydocument.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,190 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $490.12 to $490.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 21:34 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 20 | $119.76 | $2,395.20 |
DisclosureSEC source: 0001237334-26-000004 · primarydocument.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025. Read SEC document |
| February 25, 2026 Filed Feb 25, 2026 21:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Option · Derivative | 1,000 | $0.00 Strike: $119.76 | $0.00 |
DisclosureSEC source: 0001237334-26-000003 · primarydocument.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,320 Underlying: Common Stock · 1,000 shares Expires 2030-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025. Read SEC document |
| February 25, 2026 Filed Feb 25, 2026 21:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,000 | $520.00 | $520,000.00 |
DisclosureSEC source: 0001237334-26-000003 · primarydocument.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,190 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025. Read SEC document |
| February 25, 2026 Filed Feb 25, 2026 21:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,000 | $119.76 | $119,760.00 |
DisclosureSEC source: 0001237334-26-000003 · primarydocument.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025. Read SEC document |
| January 06, 2026 Filed Jan 6, 2026 21:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Option · Derivative | 1,000 | $0.00 Strike: $119.76 | $0.00 |
DisclosureSEC source: 0001237334-26-000002 · primarydocument.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,320 Underlying: Common Stock · 1,000 shares Expires 2030-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025. Read SEC document |
| January 06, 2026 Filed Jan 6, 2026 21:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,000 | $510.00 | $510,000.00 |
DisclosureSEC source: 0001237334-26-000002 · primarydocument.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,190 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025. Read SEC document |
| January 06, 2026 Filed Jan 6, 2026 21:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,000 | $119.76 | $119,760.00 |
DisclosureSEC source: 0001237334-26-000002 · primarydocument.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:59 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Option · Derivative | 1,000 | $0.00 Strike: $119.76 | $0.00 |
DisclosureSEC source: 0001237334-26-000001 · primarydocument.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,320 Underlying: Common Stock · 1,000 shares Expires 2030-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:59 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,000 | $500.01 | $500,014.60 |
DisclosureSEC source: 0001237334-26-000001 · primarydocument.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,190 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $500.00 to $500.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:59 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,000 | $119.76 | $119,760.00 |
DisclosureSEC source: 0001237334-26-000001 · primarydocument.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025. Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GiftCommon Stock | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001237334-25-000006 · primarydocument.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,190 Read SEC document |
| September 24, 2025 Filed Sep 25, 2025 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Option · Derivative | 1,000 | $0.00 Strike: $119.76 | $0.00 |
DisclosureSEC source: 0001237334-25-000004 · primarydocument.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,320 Underlying: Common Stock · 1,000 shares Expires 2030-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2025 Filed Sep 25, 2025 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,000 | $440.00 | $440,000.00 |
DisclosureSEC source: 0001237334-25-000004 · primarydocument.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,865 Read SEC document |
| September 24, 2025 Filed Sep 25, 2025 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,000 | $119.76 | $119,760.00 |
DisclosureSEC source: 0001237334-25-000004 · primarydocument.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2025 Filed Sep 2, 2025 20:39 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Option · Derivative | 3,000 | $0.00 Strike: $132.30 | $0.00 |
DisclosureSEC source: 0001237334-25-000003 · primarydocument.xml · derivative · entry 5 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2027-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. Read SEC document |
| September 02, 2025 Filed Sep 2, 2025 20:39 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,000 | $420.00 | $420,000.00 |
DisclosureSEC source: 0001237334-25-000003 · primarydocument.xml · nonDerivative · entry 4 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,865 F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. Read SEC document |
| September 02, 2025 Filed Sep 2, 2025 20:39 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,000 | $430.00 | $430,000.00 |
DisclosureSEC source: 0001237334-25-000003 · primarydocument.xml · nonDerivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,865 F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. Read SEC document |
| September 02, 2025 Filed Sep 2, 2025 20:39 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,000 | $419.63 | $419,630.00 |
DisclosureSEC source: 0001237334-25-000003 · primarydocument.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,865 F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. Read SEC document |
| September 02, 2025 Filed Sep 2, 2025 20:39 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 3,000 | $132.30 | $396,900.00 |
DisclosureSEC source: 0001237334-25-000003 · primarydocument.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:13 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Unit · Derivative | 1,190 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005513 · primarydocument.xml · derivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,190 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:13 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005513 · primarydocument.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:13 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Options · Derivative | 3,650 | $0.00 Strike: $306.41 | $0.00 |
DisclosureSEC source: 0001562180-25-005513 · primarydocument.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,650 Underlying: Common Stock · 3,650 shares Expires 2035-07-24 F3 · shares: Annual non-employee director award. Read SEC document |
| November 01, 2024 Filed Nov 4, 2024 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 510 | $376.63 | $192,080.33 |
DisclosureSEC source: 0001415889-24-025976 · form4-11042024_041104.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,675 Read SEC document |
| September 09, 2024 Filed Oct 27, 2025 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GiftCommon Stock | 225 | $0.00 | $0.00 |
DisclosureSEC source: 0001237334-25-000005 · primarydocument.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,640 F1 · date: This Form 4 reports the transfer of 225 shares of common stock on September 9, 2024, from an account jointly held by the reporting person and his son, to an account in which the reporting person has no beneficial interest. This transfer was done without the knowledge of the reporting person, and was discovered recently. As a result of this omission, the amounts of securities beneficially owned reported in subsequent Forms 4 by the reporting person were overstated. F2 · balance_after: Total reported as of the date of filing, and takes into account transactions that have occurred following the date of the original transaction reported on this Form 4. Read SEC document |
| August 21, 2024 Filed Aug 22, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 1,210 | $0.00 Strike: $132.30 | $0.00 |
DisclosureSEC source: 0001415889-24-022034 · form4-08222024_040803.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 1,210 shares Expires 2027-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2024 Filed Aug 22, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,210 | $349.00 | $422,290.00 |
DisclosureSEC source: 0001415889-24-022034 · form4-08222024_040803.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,185 Read SEC document |
| August 21, 2024 Filed Aug 22, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,210 | $132.30 | $160,083.00 |
DisclosureSEC source: 0001415889-24-022034 · form4-08222024_040803.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,395 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2024 Filed Jul 26, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 1,190 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-020172 · form4-07262024_040725.xml · derivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,190 Underlying: Common Stock · 1,190 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F2 · shares: Annual non-employee director award. F3 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date. F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 3,000 | $0.00 Strike: $112.14 | $0.00 |
DisclosureSEC source: 0001415889-24-017646 · form4-06202024_040610.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2028-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 3,000 | $304.18 | $912,538.50 |
DisclosureSEC source: 0001415889-24-017646 · form4-06202024_040610.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,185 F1 · price: This transaction was executed in multiple trades at prices ranging from $304.03 to $304.19. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 18, 2024 Filed Jun 20, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 3,000 | $112.14 | $336,420.00 |
DisclosureSEC source: 0001415889-24-017646 · form4-06202024_040610.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 2,000 | $0.00 Strike: $112.14 | $0.00 |
DisclosureSEC source: 0001415889-24-016933 · form4-06142024_040620.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 2,000 shares Expires 2028-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 2,000 | $281.53 | $563,054.80 |
DisclosureSEC source: 0001415889-24-016933 · form4-06142024_040620.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,185 F1 · price: This transaction was executed in multiple trades at prices ranging from $281.47 to $281.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,000 | $112.14 | $224,280.00 |
DisclosureSEC source: 0001415889-24-016933 · form4-06142024_040620.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2024 Filed May 16, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 2,000 | $0.00 Strike: $112.14 | $0.00 |
DisclosureSEC source: 0001415889-24-013353 · form4-05162024_040513.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 2,000 shares Expires 2028-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2024 Filed May 16, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 2,000 | $272.90 | $545,800.00 |
DisclosureSEC source: 0001415889-24-013353 · form4-05162024_040513.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,185 Read SEC document |
| May 15, 2024 Filed May 16, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,000 | $112.14 | $224,280.00 |
DisclosureSEC source: 0001415889-24-013353 · form4-05162024_040513.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2024 Filed May 6, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 2,240 | $0.00 Strike: $112.14 | $0.00 |
DisclosureSEC source: 0001415889-24-012329 · form4-05062024_040504.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 2,240 shares Expires 2028-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2024 Filed May 6, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 2,240 | $259.91 | $582,195.04 |
DisclosureSEC source: 0001415889-24-012329 · form4-05062024_040504.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,185 Read SEC document |
| May 03, 2024 Filed May 6, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,240 | $112.14 | $251,193.60 |
DisclosureSEC source: 0001415889-24-012329 · form4-05062024_040504.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 400 | $255.00 | $102,000.00 |
DisclosureSEC source: 0001415889-23-016597 · form4-12182023_041213.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,185 Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 22:29 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 3,000 | $0.00 Strike: $175.43 | $0.00 |
DisclosureSEC source: 0001415889-23-016417 · form4-12132023_101259.xml · derivative · entry 3 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2025-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 22:29 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 3,000 | $249.68 | $749,034.00 |
DisclosureSEC source: 0001415889-23-016417 · form4-12132023_101259.xml · nonDerivative · entry 2 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,585 F1 · price: This transaction was executed in multiple trades at prices ranging from $249.6369 to $249.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 22:29 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 3,000 | $175.43 | $526,290.00 |
DisclosureSEC source: 0001415889-23-016417 · form4-12132023_101259.xml · nonDerivative · entry 1 CAUSEY CHRISTOPHER · CIK 0001237334 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.